AJP - Lung Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 292: L1073-L1084, 2007. First published January 5, 2007; doi:10.1152/ajplung.00347.2006
1040-0605/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/L1073    most recent
00347.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balasubramaniam, V.
Right arrow Articles by Abman, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balasubramaniam, V.
Right arrow Articles by Abman, S. H.

Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia

Vivek Balasubramaniam, Cela F. Mervis, Anne M. Maxey, Neil E. Markham, and Steven H. Abman

Pediatric Heart Lung Center, Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado

Submitted 6 September 2006 ; accepted in final form 1 January 2007

Hyperoxia disrupts vascular and alveolar growth of the developing lung and contributes to the development of bronchopulmonary dysplasia (BPD). Endothelial progenitor cells (EPC) have been implicated in repair of the vasculature, but their role in lung vascular development is unknown. Since disruption of vascular growth impairs lung structure, we hypothesized that neonatal hyperoxia impairs EPC mobilization and homing to the lung, contributing to abnormalities in lung structure. Neonatal mice (1-day-old) were exposed to 80% O2 at Denver's altitude (= 65% at sea level) or room air for 10 days. Adult mice were also exposed for comparison. Blood, lung, and bone marrow were harvested after hyperoxia. Hyperoxia decreased pulmonary vascular density by 72% in neonatal but not adult mice. In contrast to the adult, hyperoxia simplified distal lung structure neonatal mice. Moderate hyperoxia reduced EPCs (CD45–/Sca-1+/CD133+/VEGFR-2+) in the blood (55%; P < 0.03), bone marrow (48%; P < 0.01), and lungs (66%; P < 0.01) of neonatal mice. EPCs increased in bone marrow (2.5-fold; P < 0.01) and lungs (2-fold; P < 0.03) of hyperoxia-exposed adult mice. VEGF, nitric oxide (NO), and erythropoietin (Epo) contribute to mobilization and homing of EPCs. Lung VEGF, VEGF receptor-2, endothelial NO synthase, and Epo receptor expression were reduced by hyperoxia in neonatal but not adult mice. We conclude that moderate hyperoxia decreases vessel density, impairs lung structure, and reduces EPCs in the circulation, bone marrow, and lung of neonatal mice but increases EPCs in adults. This developmental difference may contribute to the increased susceptibility of the developing lung to hyperoxia and may contribute to impaired lung vascular and alveolar growth in BPD.

lung vascular development



Address for reprint requests and other correspondence: V. Balasubramaniam, Pediatric Pulmonary Medicine, Dept. of Pediatrics, UCHSC at Fitzsimmons, Pediatrics 8317, PO Box 6511, Aurora, CO 80045 (e-mail: vivek.balasubramaniam{at}uchsc.edu)




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
T. van Haaften, R. Byrne, S. Bonnet, G. Y. Rochefort, J. Akabutu, M. Bouchentouf, G. J. Rey-Parra, J. Galipeau, A. Haromy, F. Eaton, et al.
Airway Delivery of Mesenchymal Stem Cells Prevents Arrested Alveolar Growth in Neonatal Lung Injury in Rats
Am. J. Respir. Crit. Care Med., December 1, 2009; 180(11): 1131 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Fujinaga, C. D. Baker, S. L. Ryan, N. E. Markham, G. J. Seedorf, V. Balasubramaniam, and S. H. Abman
Hyperoxia disrupts vascular endothelial growth factor-nitric oxide signaling and decreases growth of endothelial colony-forming cells from preterm infants
Am J Physiol Lung Cell Mol Physiol, December 1, 2009; 297(6): L1160 - L1169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. Balasubramaniam and D. A. Ingram
Endothelial Progenitors in the Risk of Developing Bronchopulmonary Dysplasia: Can We Include Endothelial Progenitor Cells in BPD Risk Assessment?
Am. J. Respir. Crit. Care Med., September 15, 2009; 180(6): 488 - 490.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Borghesi, M. Massa, R. Campanelli, L. Bollani, C. Tzialla, T. A. Figar, G. Ferrari, E. Bonetti, G. Chiesa, A. de Silvestri, et al.
Circulating Endothelial Progenitor Cells in Preterm Infants with Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med., September 15, 2009; 180(6): 540 - 546.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. D. Baker, S. L. Ryan, D. A. Ingram, G. J. Seedorf, S. H. Abman, and V. Balasubramaniam
Endothelial Colony-forming Cells from Preterm Infants Are Increased and More Susceptible to Hyperoxia
Am. J. Respir. Crit. Care Med., September 1, 2009; 180(5): 454 - 461.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. M. Tuder, S. H. Abman, T. Braun, F. Capron, T. Stevens, P. A. Thistlethwaite, and S. G. Haworth
Development and pathology of pulmonary hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S3 - S9.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. McGrath-Morrow, T. Lauer, M. Yee, E. Neptune, M. Podowski, R. K. Thimmulappa, M. O'Reilly, and S. Biswal
Nrf2 increases survival and attenuates alveolar growth inhibition in neonatal mice exposed to hyperoxia
Am J Physiol Lung Cell Mol Physiol, April 1, 2009; 296(4): L565 - L573.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. N. Milovanova, V. M. Bhopale, E. M. Sorokina, J. S. Moore, T. K. Hunt, M. Hauer-Jensen, O. C. Velazquez, and S. R. Thom
Lactate Stimulates Vasculogenic Stem Cells via the Thioredoxin System and Engages an Autocrine Activation Loop Involving Hypoxia-Inducible Factor 1
Mol. Cell. Biol., October 15, 2008; 28(20): 6248 - 6261.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Proceedings of the ATS, July 15, 2008; 5(5): 637 - 667.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J.-R. Tang, G. Seedorf, V. Balasubramaniam, A. Maxey, N. Markham, and S. H. Abman
Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition
Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1271 - L1280.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.